The novel tyrosine kinase inhibitor AKN-028 has significant...

Blood Cancer Journal 2012 / 8 Vol. 2; Iss. 8

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson, A, Hermanson, M, Wickström, M, Lindhagen, E, Ekholm, C, Jenmalm Jensen, A, Löthgren, A, Lehmann, F, Larsson, R, Parrow, V, Höglund, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2012.28
Date:
August, 2012
File:
PDF, 562 KB
english, 2012
Conversion to is in progress
Conversion to is failed